ProMedica Toledo Hospital is a 794-bed non-profit hospital in Toledo, Ohio operated by ProMedica. The hospital is a Level I trauma center and the largest acute care hospital in the Toledo metropolitan ...

There are 794 beds in Toledo Hospital.

During the past decade, Toledo Hospital conducted 41 clinical trials. In the 10-year time frame, 41 clinical trials started and 105 clinical trials were completed, i.e. on average, 256.1% percent of trials that started reached the finish line to date. In the past 5 years, 18 clinical trials started and 23 clinical trials were completed. i.e. 127.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Toledo Hospital" #1 sponsor was "Alliance for Clinical Trials in Oncology" with 67 trials, followed by "SWOG Cancer Research Network" with 14 trials sponsored, "Children's Oncology Group" with 12 trials sponsored, "Eastern Cooperative Oncology Group" with 11 trials sponsored and "Boston Scientific Corporation" with 11 trials sponsored. Other sponsors include 87 different institutions and companies that sponsored additional 64 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Toledo Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 127 trials as a collaborator, "NCIC Clinical Trials Group" with 11 trials as a collaborator, "Cancer and Leukemia Group B" with 8 trials as a collaborator, "SWOG Cancer Research Network" with 6 trials as a collaborator and "North Central Cancer Treatment Group" with 5 trials as a collaborator. Other collaborators include 54 different institutions and companies that were collaborators in the rest 48 trials.

According to Clinical.Site data, the most researched conditions in "Toledo Hospital" are "Breast Cancer" (36 trials), "Lung Cancer" (18 trials), "Unspecified Adult Solid Tumor, Protocol Specific" (14 trials), "Lymphoma" (11 trials) and "Leukemia" (9 trials). Many other conditions were trialed in "Toledo Hospital" in a lesser frequency.

Most popular intervention types in "Toledo Hospital" are "Drug" (131 trials), "Other" (50 trials), "Biological" (48 trials), "Device" (33 trials) and "Radiation" (28 trials). Other intervention types were less common.

The name of intervention was led by "placebo" (30 trials), "radiation therapy" (16 trials), "cyclophosphamide" (15 trials), "carboplatin" (13 trials) and "Placebo" (12 trials). Other intervention names were less common.

The vast majority of trials in "Toledo Hospital" are 169 trials for "All" genders, 31 trials for "Female" genders and 6 trials for "Male" genders.

Currently, there are NaN active trials in "Toledo Hospital". undefined are not yet recruiting, 11 are recruiting, 14 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 159 completed trials in Toledo Hospital, undefined suspended trials, and 16 terminated clinical trials to date.

Out of the total trials that were conducted in Toledo Hospital, 4 "Phase 1" clinical trials were conducted, 59 "Phase 2" clinical trials and 85 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 27 trials that are defined as “Not Applicable".

Toledo Hospital has several departments that took part in Clinical trials: "Flower Hospital Cancer Center" - 126 trials, "ProMedica Toledo Hospital/Russell J Ebeid Children's Hospital" - 280 trials, "Hickman Cancer Center" - 257 trials, "Jobst Vascular Institute" - 37 trials, "Northwest Ohio Cardiology Consultants" - 20 trials, "ProMedica Toledo Hospital/Toledo Children's Hospital/Pediatric Pulmonary & Cystic Fibrosis Center" - 9 trials, "Neurology Center of Ohio" - 5 trials, "Jobst Vascular" - 2 trials